WO2009008888A8 - African swine virus polypeptides as vaccines and its therapeutic use thereof - Google Patents

African swine virus polypeptides as vaccines and its therapeutic use thereof Download PDF

Info

Publication number
WO2009008888A8
WO2009008888A8 PCT/US2007/073189 US2007073189W WO2009008888A8 WO 2009008888 A8 WO2009008888 A8 WO 2009008888A8 US 2007073189 W US2007073189 W US 2007073189W WO 2009008888 A8 WO2009008888 A8 WO 2009008888A8
Authority
WO
WIPO (PCT)
Prior art keywords
african swine
vaccines
therapeutic use
virus polypeptides
swine virus
Prior art date
Application number
PCT/US2007/073189
Other languages
French (fr)
Other versions
WO2009008888A1 (en
Inventor
Matthias Rath
Aleksandra Niedzwiecki
Original Assignee
Matthias Rath
Aleksandra Niedzwiecki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath, Aleksandra Niedzwiecki filed Critical Matthias Rath
Priority to PCT/US2007/073189 priority Critical patent/WO2009008888A1/en
Publication of WO2009008888A1 publication Critical patent/WO2009008888A1/en
Publication of WO2009008888A8 publication Critical patent/WO2009008888A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.
PCT/US2007/073189 2007-07-10 2007-07-10 African swine virus polypeptides as vaccines and its therapeutic use thereof WO2009008888A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2007/073189 WO2009008888A1 (en) 2007-07-10 2007-07-10 African swine virus polypeptides as vaccines and its therapeutic use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/073189 WO2009008888A1 (en) 2007-07-10 2007-07-10 African swine virus polypeptides as vaccines and its therapeutic use thereof

Publications (2)

Publication Number Publication Date
WO2009008888A1 WO2009008888A1 (en) 2009-01-15
WO2009008888A8 true WO2009008888A8 (en) 2009-07-09

Family

ID=40228878

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/073189 WO2009008888A1 (en) 2007-07-10 2007-07-10 African swine virus polypeptides as vaccines and its therapeutic use thereof

Country Status (1)

Country Link
WO (1) WO2009008888A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110904127A (en) * 2018-09-18 2020-03-24 瓦赫宁恩研究基金会 African swine fever virus vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8702403A (en) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund OLIGOPEPTIDES AND THEIR USE FOR DIAGNOSTIC AND VACCINATION PURPOSES FOR AIDS AND ARC.
DE69536065D1 (en) * 1994-01-14 2010-05-27 Rath Matthias Hydrophilic Signal Oligopeptides and Methods of Therapeutic Use

Also Published As

Publication number Publication date
WO2009008888A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
WO2008083239A3 (en) Compositions and methods for stimulating an immune response
EP3266464A3 (en) Yeast-based therapeutic for chronic hepatitis b infection
CL2015000784A1 (en) Compounds derived from acylaminopyrimidine, interferon inducers; pharmaceutical composition that includes them; its use in the treatment of viral infections, immune disorders, cancer and other diseases.
WO2009156405A8 (en) Novel immunoadjuvant flagellin-based compounds and use thereof
TN2012000414A1 (en) Forms of rifaximin and uses thereof
WO2007147529A3 (en) Recombinant viral vaccine
WO2013059559A3 (en) Compounds and methods for enhancing innate immune responses
WO2013106689A8 (en) Hcv ns3 protease inhibitors
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
WO2008134643A3 (en) Trypanosoma antigens, vaccine compositions, and related methods
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
MX2012001495A (en) Porphyromonas gingivalis polypeptides.
WO2015031778A3 (en) Compositions and methods for the treatment or prevention of tuberculosis
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
WO2012061248A8 (en) Novel specific hcv ns3 protease inhibitors
CR9300A (en) USE OF IRON COMPOUNDS (III)
WO2015054678A3 (en) Human papilloma virus therapeutic vaccine
MX2013003245A (en) Bvdv vaccine.
WO2011044570A3 (en) Recombinant antibodies against h1n1 influenza
MX2007002659A (en) Vaccine composition against hepatitis c virus.
WO2013095091A3 (en) Rsv g protein specific antibodies
MX2011006516A (en) Hepatitis c virus combination therapy.
WO2007120603A3 (en) Immunogenic bcr-abl peptides and methods of use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07799469

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07799469

Country of ref document: EP

Kind code of ref document: A1